RankingsPricing
  1. US-listed companies
  2. ABBOTT LABORATORIES
  3. Financials
  4. Total current assets

ABBOTT LABORATORIESABT

Market cap
$223B
P/E ratio
SummaryFinancials
Period EndTotal current assets (Million USD)YoY (%)
Dec 31, 202423,656+4.35%
Dec 31, 202322,670-10.13%
Dec 31, 202225,224+4.06%
Dec 31, 202124,239+18.58%
Dec 31, 202020,441+30.47%
Dec 31, 201915,667+7.07%
Dec 31, 201814,632-27.37%
Dec 31, 201720,147-24.76%
Dec 31, 201626,776+89.16%
Dec 31, 201514,155-7.25%
Dec 31, 201415,261-20.71%
Dec 31, 201319,247-38.55%
Dec 31, 201231,323+31.78%
Dec 31, 201123,769+6.50%
Dec 31, 201022,318

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)